Literature DB >> 20927611

An overview of mood disorders in the DSM-5.

Jan Fawcett1.   

Abstract

The process of revising the DSM, which is based on new findings in the literature and experience with the current classification, is initiated every 12-18 years. The process for the revision of DSM-IV to the DSM-5 began in 2006-after a series of meeting proceedings and monographs were published during the previous 3 years-with the appointment of diagnostic group chairs by Director Dr. David Kupfer and Vice Director Dr. Darrel Regier. Members were recruited for workgroups to review the existing DSM-IV, to decide what worked well and which areas needed change, to review the available literature and data, and to propose changes based on an appropriate level of evidence in the literature proportional to the significance of the change. At the halfway point in this process, the Mood Disorders Workgroup has made tentative recommendations to be tested in field trials. These recommendations and some of the basis for them are discussed in this review. Final decisions await the data from field trials, possible revisions by the workgroups, and action by the task force. This article describes some of the recommendations made by the Mood Disorders Workgroup at this point in the process.

Entities:  

Mesh:

Year:  2010        PMID: 20927611     DOI: 10.1007/s11920-010-0154-2

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  37 in total

1.  Clinical predictors of suicide in primary major depressive disorder.

Authors:  William Coryell; Elizabeth A Young
Journal:  J Clin Psychiatry       Date:  2005-04       Impact factor: 4.384

2.  Suicide attempts preceding completed suicide.

Authors:  E T Isometsä; J K Lönnqvist
Journal:  Br J Psychiatry       Date:  1998-12       Impact factor: 9.319

3.  Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

Authors:  M K Spearing; R M Post; G S Leverich; D Brandt; W Nolen
Journal:  Psychiatry Res       Date:  1997-12-05       Impact factor: 3.222

4.  The Altman Self-Rating Mania Scale.

Authors:  E G Altman; D Hedeker; J L Peterson; J M Davis
Journal:  Biol Psychiatry       Date:  1997-11-15       Impact factor: 13.382

Review 5.  Update on partial response in depression.

Authors:  Michael E Thase
Journal:  J Clin Psychiatry       Date:  2009       Impact factor: 4.384

6.  Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.

Authors:  Huaiyu Yang; Sarah Chuzi; Lara Sinicropi-Yao; Dan Johnson; Ying Chen; Alisabet Clain; Lee Baer; Patrick J McGrath; Jonathan W Stewart; Maurizio Fava; George I Papakostas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

7.  Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sample.

Authors:  Vito Agosti; Jonathan W Stewart
Journal:  J Affect Disord       Date:  2007-10-25       Impact factor: 4.839

8.  Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.

Authors:  Joseph F Goldberg; Roy H Perlis; Charles L Bowden; Michael E Thase; David J Miklowitz; Lauren B Marangell; Joseph R Calabrese; Andrew A Nierenberg; Gary S Sachs
Journal:  Am J Psychiatry       Date:  2009-01-02       Impact factor: 18.112

9.  Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.

Authors:  George I Papakostas; Patrick McGrath; Jonathan Stewart; Dana Charles; Ying Chen; David Mischoulon; Christina Dording; Maurizio Fava
Journal:  Psychiatry Res       Date:  2008-08-27       Impact factor: 3.222

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  3 in total

Review 1.  DSM-5 and Mental Disorders in Older Individuals: An Overview.

Authors:  Perminder S Sachdev; Adith Mohan; Lauren Taylor; Dilip V Jeste
Journal:  Harv Rev Psychiatry       Date:  2015 Sep-Oct       Impact factor: 3.732

2.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-14       Impact factor: 5.270

3.  Validity of the bereavement exclusion to major depression: does the empirical evidence support the proposal to eliminate the exclusion in DSM-5?

Authors:  Jerome C Wakefield; Michael B First
Journal:  World Psychiatry       Date:  2012-02       Impact factor: 49.548

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.